TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3536151

Group type: EXPERIMENTAL
Intervention: Cholestyramine
Number of subjects: 3796

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3796

Group type: COMPARATOR
Intervention: Cholestyramine vs Placebo
Number of subjects: 3796
Study: 31591117

Group type: EXPERIMENTAL
Intervention: Early Bayesian dose adjustment of vancomycin
Number of subjects: 99

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 99
Study: 28804889

Group type: EXPERIMENTAL
Intervention: Disposcope-assisted double-lumen tube placement
Number of subjects: 54

Group type: COMPARATOR
Intervention: Conventional blind placement
Number of subjects: 54
Study: 25714534

Group type: EXPERIMENTAL
Intervention: Proparacaine 0.5% drops (Group Drops)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Proparacaine 0.5% drops plus subconjunctival lidocaine (Group SC)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 2% lidocaine gel (Group Gel)
Number of subjects: 92
Study: 25169158

Group type: EXPERIMENTAL
Intervention: Attitudes about school drinking fountains (measured on a 5-point scale)
Number of subjects: 3211

Group type: EXPERIMENTAL
Intervention: Intentions to drink water at school
Number of subjects: 3211
Study: 22645171

Group type: EXPERIMENTAL
Intervention: Probiotic (Lactobacillus salivarius, 2 × 10^10 bacterium colony-forming units)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 19086814

Group type: EXPERIMENTAL
Intervention: Male circumcision (MC)
Number of subjects: 1264

Group type: COMPARATOR
Intervention: Control (uncircumcised)
Number of subjects: 1264
Study: 17339157

Group type: EXPERIMENTAL
Intervention: 7.5 mL autologous blood
Number of subjects: 33

Group type: COMPARATOR
Intervention: 15 mL autologous blood
Number of subjects: 33
Study: 14998957

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate challenge test (CCCT)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Basal FSH (bFSH)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Exogenous FSH ovarian reserve test (EFORT)
Number of subjects: 85
Study: 12018735

Group type: EXPERIMENTAL
Intervention: Cisplatin plus vinorelbine
Number of subjects: 222

Group type: COMPARATOR
Intervention: Carboplatin plus paclitaxel
Number of subjects: 222
Study: 9854760

Group type: EXPERIMENTAL
Intervention: Self-management group intervention
Number of subjects: 255

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 255
Study: 7503087

Group type: EXPERIMENTAL
Intervention: Tamoxifen 20 mg/d
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 2089087

Group type: EXPERIMENTAL
Intervention: Moclobemide (300-600 mg/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Imipramine (100-200 mg/d)
Number of subjects: 0
Study: 314760

Group type: EXPERIMENTAL
Intervention: Dobutamine (2 microgram/kg . min and 4 microgram/kg . min)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Dopamine (4 microgram/kg . min and 8 microgram/kg . min)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Both catecholamines
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Dobutamine
Number of subjects: 17
Study: 30117365

Group type: EXPERIMENTAL
Intervention: BCAA (20 g/day)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Omega-3 (2,700 mg/day)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (no supplementation)
Number of subjects: 11
Study: 25138127

Group type: EXPERIMENTAL
Intervention: EX-B2 group
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: SP6 group
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 180
Study: 25669080

Group type: EXPERIMENTAL
Intervention: McGrath laryngoscope
Number of subjects: 50

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 50
Study: 21450647

Group type: EXPERIMENTAL
Intervention: Cardiopulmonary exercise testing (CPX) in AAA patients
Number of subjects: 306

Group type: COMPARATOR
Intervention: Referral group (age-matched veterans)
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Duke Treadmill Score and VA Treadmill Scores
Number of subjects: 306
Study: 19736331

Group type: EXPERIMENTAL
Intervention: Communities That Care (CTC) prevention system
Number of subjects: 4407

Group type: COMPARATOR
Intervention: Control
Number of subjects: 4407
Study: 17456506

Group type: EXPERIMENTAL
Intervention: Twin Block (TB) appliance
Number of subjects: 62

Group type: COMPARATOR
Intervention: Dynamax appliance
Number of subjects: 62
Study: 14746575

Group type: EXPERIMENTAL
Intervention: Nateglinide
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Glibenclamide
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 11414347

Group type: EXPERIMENTAL
Intervention: Motivational enhancement intervention with individual and housewide feedback components
Number of subjects: 120

Group type: COMPARATOR
Intervention: Treatment-as-usual control condition
Number of subjects: 120
Study: 9740261

Group type: EXPERIMENTAL
Intervention: Artemether 300 mg plus Pyrimethamine 100 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Artemether 300 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Pyrimethamine 100 mg
Number of subjects: 8
Study: 8036963

Group type: EXPERIMENTAL
Intervention: Self-help smoking-cessation intervention
Number of subjects: 0
Study: 2725087

Group type: EXPERIMENTAL
Intervention: Clinical algorithms (CA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prose
Number of subjects: 0
Study: 30768192

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Patient-Centered Assessment and Counseling for Exercise (PACE)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Control
Number of subjects: 174

Group type: COMPARATOR
Intervention: Comparison of MI and Control
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Comparison of PACE and MI
Number of subjects: 174
Study: 29191232

Group type: EXPERIMENTAL
Intervention: Active surveillance system
Number of subjects: 70

Group type: COMPARATOR
Intervention: Passive surveillance system
Number of subjects: 70
Study: 25480617

Group type: EXPERIMENTAL
Intervention: Vertical periumbilical incision (VW)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Transverse left iliac fossa incision (TW)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both VW and TW
Number of subjects: 40
Study: 23607501

Group type: EXPERIMENTAL
Intervention: TAFF (Separation Anxiety Family Therapy)
Number of subjects: 64

Group type: COMPARATOR
Intervention: CC (Coping Cat)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both TAFF and CC
Number of subjects: 64
Study: 21479682

Group type: EXPERIMENTAL
Intervention: Sivelestat administered until postoperative day (POD) 2 (Group A)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sivelestat administered until postoperative day (POD) 5 (Group B)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Historical controls without Sivelestat administration
Number of subjects: 30
Study: 19783715

Group type: EXPERIMENTAL
Intervention: Phentermine 15 mg with Taranabant 0.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phentermine 15 mg with Taranabant 2 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Phentermine 15 mg without Taranabant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phentermine 15 mg with Taranabant 1 mg
Number of subjects: 0
Study: 16981054

Group type: EXPERIMENTAL
Intervention: Transport with platelet GP IIb/IIIa receptor inhibitor (tirofiban; 10 mg/kg IV bolus followed by 0.1 mg/kg/min infusion during transport)
Number of subjects: 341

Group type: COMPARATOR
Intervention: Thrombolytic therapy alone
Number of subjects: 341
Study: 15063915

Group type: EXPERIMENTAL
Intervention: High-intensity hospital programs
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Low-intensity programs
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: High-intensity programs
Number of subjects: 230

Group type: COMPARATOR
Intervention: Hospital-based or community-based programs
Number of subjects: 230
Study: 10649158

Group type: EXPERIMENTAL
Intervention: Evidence-based patient education methods (including the videocassette Commit to Quit During and After Pregnancy, the publication A Pregnant Woman's Guide to Quit Smoking, and a brief counseling session)
Number of subjects: 265

Group type: COMPARATOR
Intervention: Standardized risk information and advice to quit smoking (Control group)
Number of subjects: 265
Study: 9038856

Group type: EXPERIMENTAL
Intervention: Regular human insulin at 2.0 mU.kg‐1.min‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Regular human insulin at 4.0 mU.kg‐1.min‐1
Number of subjects: 0
Study: 8587082

Group type: EXPERIMENTAL
Intervention: Nabumetone 1000-1500 mg po daily
Number of subjects: 382

Group type: COMPARATOR
Intervention: Diclofenac SR 100-150 mg po daily
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Nabumetone
Number of subjects: 382
Study: 2666249

Group type: EXPERIMENTAL
Intervention: SMS 201-995 (octreotide, Sandostatin)
Number of subjects: 273

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 273
Study: 738150

Group type: EXPERIMENTAL
Intervention: Instructional day-care program designed to prevent socioculturally caused mental retardation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonintervention control group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Instructional day-care program
Number of subjects: 0
Study: 30837453

Group type: EXPERIMENTAL
Intervention: 10 Hz‐tACS
Number of subjects: 32

Group type: COMPARATOR
Intervention: 40 Hz‐tACS
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 32
Study: 28710373

Group type: EXPERIMENTAL
Intervention: Random alterations preserving degree distribution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Different types of random alterations
Number of subjects: 0
Study: 27281304

Group type: EXPERIMENTAL
Intervention: Menstralean (diet and exercise program tailored to menstrual cycle)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (simple energy restriction)
Number of subjects: 60
Study: 23596006

Group type: EXPERIMENTAL
Intervention: Intracoronary injection of bone marrow-derived mononuclear cells (BM-MNC) early (5 to 7 days after MI)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Intracoronary injection of bone marrow-derived mononuclear cells (BM-MNC) late (3 to 4 weeks after MI)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no BM-MNC treatment)
Number of subjects: 200
Study: 21768729

Group type: EXPERIMENTAL
Intervention: Brochure presented before questionnaire
Number of subjects: 0

Group type: COMPARATOR
Intervention: Brochure presented after questionnaire
Number of subjects: 0
Study: 20143531

Group type: EXPERIMENTAL
Intervention: Bevacizumab (1.25 mg administered into the vitreous body)
Number of subjects: 56
Study: 17117128

Group type: EXPERIMENTAL
Intervention: Goal-directed therapy
Number of subjects: 224

Group type: COMPARATOR
Intervention: Non-goal-directed therapy
Number of subjects: 224
Study: 14967062

Group type: EXPERIMENTAL
Intervention: Anti-TNF therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11342894

Group type: EXPERIMENTAL
Intervention: Crushed tablets
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Chewed tablets
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Oral solution
Number of subjects: 16

Group type: COMPARATOR
Intervention: Whole tablets
Number of subjects: 16
Study: 1833301

Group type: EXPERIMENTAL
Intervention: 30 mg DHAS i.v. administration
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 6623364

Group type: EXPERIMENTAL
Intervention: CPAP/IMV (high tidal volumes 12 to 18 ml/kg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: ZEEP/A-CM (low tidal volumes 8 to 10 ml/kg)
Number of subjects: 18
Study: 31852061

Group type: EXPERIMENTAL
Intervention: Microendoscopic discectomy (MED)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Open discectomy (OLD)
Number of subjects: 60
Study: 28174353

Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg daily for 30 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 26414343

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention including motivational interviewing and behavior change techniques
Number of subjects: 275

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 275
Study: 24293094

Group type: EXPERIMENTAL
Intervention: SQDL (squats and deadlifts)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: ABADD (standing hip abductions and adductions)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: COMBO (squat/deadlift and abduction/adduction)
Number of subjects: 22
Study: 22854880

Group type: EXPERIMENTAL
Intervention: Cocoa beverages (30-900 mg flavanol per day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Green tea (matched to cocoa beverage for monomeric flavanol content)
Number of subjects: 20
Study: 18634706

Group type: EXPERIMENTAL
Intervention: 6-week herring diet (150 g baked herring fillets/d, 5 d/week)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Reference diet (150 g baked lean pork and chicken fillets/d, 5 d/week)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 6-week herring diet
Number of subjects: 35
Study: 17961422

Group type: EXPERIMENTAL
Intervention: Pravastatin (20 mg/d on top of standard therapy)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control (standard therapy)
Number of subjects: 61
Study: 15082429

Group type: EXPERIMENTAL
Intervention: Early discharge and rehabilitation service
Number of subjects: 370
Study: 11819179

Group type: EXPERIMENTAL
Intervention: Genotype resistance testing
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Expert advice with genotype data
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Phenotype resistance testing
Number of subjects: 142

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 142
Study: 9824387

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide (1600 microg/day)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide (1600 microg/day) plus oral prednisolone (5 mg/day)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 7650226

Group type: EXPERIMENTAL
Intervention: 80-mg immediate-release (IR) tablet, phase A
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Two 80-mg IR tablets, phase B
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 160-mg controlled-release capsule, phase C
Number of subjects: 12

Group type: COMPARATOR
Intervention: 10-mg IV bolus, phase D
Number of subjects: 12
Study: 2192716

Group type: EXPERIMENTAL
Intervention: Dispersible tablets (2 X 150 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Film-coated tablets (2 X 150 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 422304

Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 17

Group type: COMPARATOR
Intervention: Combination of propranolol and dihydrallazine
Number of subjects: 17
Study: 30968987

Group type: EXPERIMENTAL
Intervention: RE-AIM framework implementation
Number of subjects: 72
Study: 28411506

Group type: COMPARATOR
Intervention: Care As Usual (CAU)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Psychoeducational Prevention program (PEP)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Psychiatric Consultation followed by PEP (PC+PEP)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy followed by PEP (CBT+PEP)
Number of subjects: 166
Study: 25256567

Group type: EXPERIMENTAL
Intervention: Standard hemodiafiltration (HDF) with bicarbonate (34 mmol/L) and acetate dialysate (3 mmol/L)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Acetate-free biofiltration (AFB) without base in the dialysate
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Standard hemodiafiltration (HDF)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Acetate-free biofiltration (AFB)
Number of subjects: 22
Study: 23666460

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham RIPC (Control)
Number of subjects: 40
Study: 21857144

Group type: EXPERIMENTAL
Intervention: Triple antiplatelet therapy (TAT; addition of cilostazol to dual antiplatelet therapy)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy (DAT)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Addition of cilostazol to DAT
Number of subjects: 900

Group type: COMPARATOR
Intervention: CCB without concomitant cilostazol use
Number of subjects: 900
Study: 19232034

Group type: EXPERIMENTAL
Intervention: Insulin Aspart (IAsp)
Number of subjects: 322

Group type: COMPARATOR
Intervention: Human Insulin (HI)
Number of subjects: 322
Study: 17503066

Group type: EXPERIMENTAL
Intervention: Antibiotic ointment with hydrocortisone acetate (AB + HC)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Antibiotic ointment (AB)
Number of subjects: 151
Study: 15025615

Group type: EXPERIMENTAL
Intervention: Ketamine 0.4 mg kg(‐1)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Lidocaine 2.5 mg kg(‐1)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 10
Study: 11205522

Group type: EXPERIMENTAL
Intervention: Welfare-sponsored, government-funded job training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonparticipants (control group)
Number of subjects: 0
Study: 9161392

Group type: EXPERIMENTAL
Intervention: DVT prophylaxis using low-dose heparin sodium therapy (5000 U every 12 hours) and calf-length intermittent mechanical compression devices
Number of subjects: 98

Group type: COMPARATOR
Intervention: No DVT prophylaxis
Number of subjects: 98
Study: 7954768

Group type: EXPERIMENTAL
Intervention: Excimer laser coronary angioplasty (ELCA) alone
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Excimer laser coronary angioplasty (ELCA) plus balloon dilatation
Number of subjects: 29

Group type: COMPARATOR
Intervention: PTCA alone
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Excimer laser coronary angioplasty (ELCA)
Number of subjects: 29
Study: 2881573

Group type: EXPERIMENTAL
Intervention: Diazepam (5 mg)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Buspirone (5 or 10 mg)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 28838263

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) 10-15 mg/week for minimum 12 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (healthy subjects)
Number of subjects: 21
Study: 26743808

Group type: EXPERIMENTAL
Intervention: Forming implementation intentions with a 'volitional help sheet'
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Self-generating implementation intentions without help
Number of subjects: 226

Group type: COMPARATOR
Intervention: Thinking about triggers and coping, but not forming implementation intentions
Number of subjects: 226
Study: 26520413

Group type: EXPERIMENTAL
Intervention: Prebiotic supplementation with inulin (10 g/day)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 22793877

Group type: EXPERIMENTAL
Intervention: Structured birth planning and travel facilitation
Number of subjects: 29295

Group type: EXPERIMENTAL
Intervention: Structured birth planning
Number of subjects: 29295

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 29295
Study: 18823395

Group type: EXPERIMENTAL
Intervention: 2 mg zoledronate i.v. every 3 months for 2 years (8 infusions)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Normal saline (placebo) every 3 months for 2 years (8 infusions)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 22
Study: 17448044

Group type: EXPERIMENTAL
Intervention: Preventive programmes (group followed-up every 2 months)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Professional tooth cleaning
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Any of the test programmes
Number of subjects: 400
Study: 15125825

Group type: COMPARATOR
Intervention: Insulin in addition to unchanged oral hypoglycemic medication (IC group)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Insulin monotherapy (IM group)
Number of subjects: 64
Study: 12563567

Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 2 mg o.d.
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 4 mg o.d.
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 8 mg o.d.
Number of subjects: 280
Study: 9839267

Group type: EXPERIMENTAL
Intervention: Protocol group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonprotocol group
Number of subjects: 0
Study: 7734797

Group type: EXPERIMENTAL
Intervention: Human milk
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Formula C (similar to B with added marine oil)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Formula A (based on corn oil)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Formula B (based on soy oil supplying LNA)
Number of subjects: 0
Study: 2643865

Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 93

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 93
Study: 4602827

Group type: EXPERIMENTAL
Intervention: Carbenicillin indanyl sodium
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Ampicillin
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Cephalexin
Number of subjects: 61
Study: 30461597

Group type: EXPERIMENTAL
Intervention: Self-test instructions developed by the Health Outcomes through Motivation and Education Project and a photo story information brochure about cervical cancer
Number of subjects: 103

Group type: COMPARATOR
Intervention: Self-test instructions developed by the device manufacturer and a standard information brochure about cervical cancer
Number of subjects: 103
Study: 28974305

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided SGB (n = 20) with a 6-mL injection of 1% lidocaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham procedure (n = 20) with a 6-mL injection of 0.9% saline
Number of subjects: 40
Study: 27358638

Group type: EXPERIMENTAL
Intervention: Moderate aerobic exercise training plus diet regimen
Number of subjects: 100

Group type: COMPARATOR
Intervention: No treatment intervention (Control)
Number of subjects: 100
Study: 24002348

Group type: EXPERIMENTAL
Intervention: Walking intervention
Number of subjects: 37